North America DNA Sequencing Market Report
RA00005
North America DNA Sequencing Market by Product (Consumable, Instrument, and Service), Application (Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others), Technology (Synthesis, Ion Semiconductor Sequencing, Sequencing By Ligation, Pyrosequencing, Single Molecule Real-Time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing Technologies), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Opportunity Analysis and Industry Forecast, 2019–2025
Update Available On-Demand
North American DNA Sequencing Market Overview 2025:
The North American DNA sequencing market accounted for $3256 million in 2018 and is expected to reach $9,154 million by 2025, registering a CAGR of 15.9% from 2019 to 2025.
DNA sequencing is a technique for determining the nucleotide sequence of DNA strand. It is an important tool for identifying and understanding a specific genetic disease, forensics, cancer diagnostics, genetic profiling and pharmacogenomics. Upcoming trends in the personalized genomics for treating various diseases, genetic disorders and advancements in the DNA sequencing procedures along with rising prevalence in pre-natal & neo-natal disorders and cancers across the North American region are driving the growth of the market. However, dearth of skilled professionals, ethical & legal limitations related to DNA sequencing, and standardization concerns in sequencing procedures impede the market growth.
North America has been the traditional stronghold for DNA sequencing technologies since a long time due to continuous improvement, availability, and accessibility of DNA sequencing in this region. Several global manufacturers of DNA sequencing, platforms, equipment, and technologies are active in North America, especially in the U.S. Global DNA sequencing giants, such as Illumina, Thermo Fisher Scientific, and others have their corporate presence in this region. Hence, most of the DNA sequencing products and platforms are first launched in the U.S., and then released to other regions of the world. Moreover, this region is inundated with local and regional vendors that are gradually carving out a position in this market. For instance, Swift Biosciences, a U.S.-based biotechnology research company that specializes in manufacturing kits and reagents employed in sample preparation for next generation sequencing.
North America DNA Sequencing Market SEGMENTATION
Based on product, the North American DNA sequencing market is classified into consumable, instrument, and service. Based on Application, the market is divided into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, forensics, and others. Based on Technology, the North American DNA sequencing market is segmented into synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real-time sequencing, chain termination sequencing, and nanopore sequencing technologies. Based on end-user, the market is divided into academic & government research institutes, pharmaceutical companies, biotechnology companies, and hospitals & clinics.
Segment review
Based on product, the consumable segment acquired the largest North America DNA sequencing market share in 2018 and constitute a dominant share in 2025 due to the use and necessity in sample preparation and in pre-requisite stages of DNA sequencing. Additionally, the increasing use of DNA analyzer, fluorometer, capillary electrophoresis and genetic analyzer is fueling the growth of instruments segment. The biomarker and cancer segment is the highest contributor to the North America DNA sequencing as a result of technological advancements and increase in DNA sequencing applications. The personalized medicine segment is anticipated to be a lucrative segment owing to the rise in use of precision medicine wherein the treatment takes in account the individual’s variation in the genes, lifestyle and environment. Therefore, these factors contribute toward the growth of the North American DNA sequencing market.
According to technology, the sequencing by synthesis segment was the highest contributor to the North America DNA sequencing market owing to the wide use of DNA sequencing platforms in sequencing protocols and is likely to continue the dominance throughout the forecasting period. Furthermore, the pyrosequencing segment is growing with the highest CAGR is expected to continue its trend in 2025. Moreover, the research institute segment was the highest contributor to the North America DNA sequencing in 2018 and is occupying the largest share in the North American DNA sequencing market due to the presence of large number of research centers in this region and ongoing research. Also, the biotechnology company segment is likely to achieve the fastest CAGR owing to the presence of major biotechnology players in this region.
North America occupied the largest share of the market in 2018 and is expected to maintain its dominance during the forecast period owing to supportive government initiatives and rising incidences of cancers in U.S. and Canada. Thus, generating the highest revenue for the DNA sequencing market and creating awareness amongst the population in the north American region. According to National Cancer Institute, in 2018, an estimated 1,735,350 new cases of cancer were diagnosed in the U.S. For instance, the “Precision Medicine Initiative” launched in U.S. has helped in taking precautionary measures and treating diseases specific to the patient's characteristics by incorporating the volunteer data collected by the healthcare providers and the patients. Currently, the U.S. government is focusing on providing better cancer treatments due to higher prevalence rate of the cancer in the country, which is indirectly propelling the growth of DNA sequencing market in North American region.
The major companies profiled in this report include Abbott Laboratories, Agilent Technologies Inc., Danaher Corporation, Illumina, Inc., LI-COR Biosciences, Inc., Pacific Biosciences of California, Inc., Thermo Fisher Scientific Inc., ZS Genetics, Inc., Bio-Rad Laboratories, Inc., and Myriad Genetics, Inc. The other players operating in the market are Oxford Nanopore Technologies, Ltd., Genia Technologies, Inc., Hamilton Thorne, Inc. among others.
KEY MARKET BENEFITS
- This report entails a detailed quantitative analysis along with the current North America DNA Sequencing market trends from 2019 to 2025 to identify the prevailing opportunities for the market growth.
- The market forecast is studied from 2019 to 2025.
- The market size and estimations are based on a comprehensive analysis of key developments in the North America DNA Sequencing Market.
- A qualitative analysis based on innovative products facilitates strategic business planning.
- The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.
KEY MARKET SEGMENTS
By Product
- Consumable
- Instrument
- Service
By Application
- Biomarkers & Cancer
- Diagnostics
- Reproductive Health
- Personalized Medicine
- Forensics
- Others
By Technology
- Synthesis
- Ion Semiconductor Sequencing
- Sequencing by Ligation
- Pyrosequencing
- Single Molecule Real-time Sequencing
- Chain Termination Sequencing
- Nanopore Sequencing Technologies
By End User
- Academic & Government Research Institutes
- Pharmaceutical Companies
- Biotechnology Companies
- Personalized Medicine
- Hospitals & Clinics
By Region
- North America
- U.S.
- Canada
- Mexico
CHAPTER 1: INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY MARKET SEGMENTS
1.3. KEY BENEFITS
1.4. RESEARCH METHODOLOGY
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3: MARKET LANDSCAPE
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTER'S FIVE FORCES ANALYSIS
3.3.1. Bargaining power of suppliers
3.3.2. Threat of new entrants
3.3.3. Threat of substitutes
3.3.4. Competitive rivalry
3.3.5. Bargaining power among buyers
3.4. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING
3.4.1. Market share analysis/top player positioning 2018
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4: NORTH AMERICA DNA SEQUENCING MARKET BY PRODUCT
4.1. OVERVIEW
4.2. CONSUMABLE
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market Size and Forecast by country
4.3. INSTRUMENT
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market Size and Forecast by country
4.4. SERVICE
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market Size and Forecast by country
CHAPTER 5: NORTH AMERICA DNA SEQUENCING MARKET BY APPLICATION
5.1. OVERVIEW
5.2. BIOMARKERS AND CANCER
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market Size and Forecast by country
5.3. DIAGNOSTICS
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market Size and Forecast by country
5.4. REPRODUCTIVE HEALTH
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market Size and Forecast by country
5.5. PERSONALIZED MEDICINE
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market Size and Forecast by country
5.6. FORENSICS
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market Size and Forecast by country
5.7. OTHERS
5.7.1. Key market trends, growth factors and opportunities
5.7.2. Market Size and Forecast by country
CHAPTER 6: NORTH AMERICA DNA SEQUENCING MARKET BY TECHNOLOGY
6.1. OVERVIEW
6.2. SYNTHESIS
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market Size and Forecast by country
6.3. ION SEMICONDUCTOR SEQUENCING
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market Size and Forecast by country
6.4. SEQUENCING BY LIGATION
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market Size and Forecast by country
6.5. PYROSEQUENCING
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market Size and Forecast by country
6.6. SINGLE MOLECULE REAL-TIME SEQUENCING
6.6.1. Key market trends, growth factors and opportunities
6.6.2. Market Size and Forecast by country
6.7. CHAIN TERMINATION SEQUENCING
6.7.1. Key market trends, growth factors and opportunities
6.7.2. Market Size and Forecast by country
6.8. NANOPORE SEQUENCING TECHNOLOGIES
6.8.1. Key market trends, growth factors and opportunities
6.8.2. Market Size and Forecast by country
CHAPTER 7: NORTH AMERICA DNA SEQUENCING MARKET BY END USER
7.1. OVERVIEW
7.2. ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market Size and Forecast by country
7.3. PHARMACEUTICAL COMPANIES
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market Size and Forecast by country
7.4. BIOTECHNOLOGY COMPANIES
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market Size and Forecast by country
7.5. PERSONALIZED MEDICINE
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market Size and Forecast by country
7.6. HOSPITALS AND CLINICS
7.6.1. Key market trends, growth factors and opportunities
7.6.2. Market Size and Forecast by country
CHAPTER 8: NORTH AMERICA DNA SEQUENCING MARKET BY COUNTRY
8.1. OVERVIEW
8.2. U.S. AMERICA DNA SEQUENCING MARKET
8.2.1. Market size and forecast by product
8.2.2. Market size and forecast by application
8.2.3. Market size and forecast by technology
8.2.4. Market size and forecast by end user
8.3. Canada AMERICA DNA SEQUENCING MARKET
8.3.1. Market size and forecast by product
8.3.2. Market size and forecast by application
8.3.3. Market size and forecast by technology
8.3.4. Market size and forecast by end user
8.4. Mexico AMERICA DNA SEQUENCING MARKET
8.4.1. Market size and forecast by product
8.4.2. Market size and forecast by application
8.4.3. Market size and forecast by technology
8.4.4. Market size and forecast by end user
CHAPTER 9: COMPANY PROFILES
9.1. ABBOTT LABORATORIES
9.1.1. Company overview
9.1.2. Business performance
9.1.3. Key strategic moves and developments
9.2. AGILENT TECHNOLOGIES, INC.
9.2.1. Company overview
9.2.2. Business performance
9.2.3. Key strategic moves and developments
9.3. DANAHER CORPORATION
9.3.1. Company overview
9.3.2. Business performance
9.3.3. Key strategic moves and developments
9.4. ILLUMINA, INC.
9.4.1. Company overview
9.4.2. Business performance
9.4.3. Key strategic moves and developments
9.5. LI-COR BIOSCIENCES, INC.
9.5.1. Company overview
9.5.2. Business performance
9.5.3. Key strategic moves and developments
9.6. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
9.6.1. Company overview
9.6.2. Business performance
9.6.3. Key strategic moves and developments
9.7. THERMO FISHER SCIENTIFIC, INC.
9.7.1. Company overview
9.7.2. Business performance
9.7.3. Key strategic moves and developments
9.8. ZS GENETICS, INC.
9.8.1. Company overview
9.8.2. Business performance
9.8.3. Key strategic moves and developments
9.9. BIO-RAD LABORATORIES, INC.
9.9.1. Company overview
9.9.2. Business performance
9.9.3. Key strategic moves and developments
9.10. MYRIAD GENETICS, INC.
9.10.1. Company overview
9.10.2. Business performance
9.10.3. Key strategic moves and developments
LIST OF TABLES
TABLE 1. NORTH AMERICA DNA SEQUENCING MARKET, BY PRODUCT 2018-2026 ($MILLION)
TABLE 2. NORTH AMERICA DNA SEQUENCING MARKET FOR CONSUMABLE, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 3. NORTH AMERICA DNA SEQUENCING MARKET FOR INSTRUMENT, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 4. NORTH AMERICA DNA SEQUENCING MARKET FOR SERVICE, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 5. NORTH AMERICA DNA SEQUENCING MARKET, BY APPLICATION 2018-2026 ($MILLION)
TABLE 6. NORTH AMERICA DNA SEQUENCING MARKET FOR BIOMARKERS AND CANCER, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 7. NORTH AMERICA DNA SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 8. NORTH AMERICA DNA SEQUENCING MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 9. NORTH AMERICA DNA SEQUENCING MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 10. NORTH AMERICA DNA SEQUENCING MARKET FOR FORENSICS, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 11. NORTH AMERICA DNA SEQUENCING MARKET FOR OTHERS, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 12. NORTH AMERICA DNA SEQUENCING MARKET, BY TECHNOLOGY 2018-2026 ($MILLION)
TABLE 13. NORTH AMERICA DNA SEQUENCING MARKET FOR SYNTHESIS, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 14. NORTH AMERICA DNA SEQUENCING MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 15. NORTH AMERICA DNA SEQUENCING MARKET FOR SEQUENCING BY LIGATION, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 16. NORTH AMERICA DNA SEQUENCING MARKET FOR PYROSEQUENCING, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 17. NORTH AMERICA DNA SEQUENCING MARKET FOR SINGLE MOLECULE REAL-TIME SEQUENCING, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 18. NORTH AMERICA DNA SEQUENCING MARKET FOR CHAIN TERMINATION SEQUENCING, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 19. NORTH AMERICA DNA SEQUENCING MARKET FOR NANOPORE SEQUENCING TECHNOLOGIES, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 20. NORTH AMERICA DNA SEQUENCING MARKET, BY END USER 2018-2026 ($MILLION)
TABLE 21. NORTH AMERICA DNA SEQUENCING MARKET FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 22. NORTH AMERICA DNA SEQUENCING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 23. NORTH AMERICA DNA SEQUENCING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 24. NORTH AMERICA DNA SEQUENCING MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 25. NORTH AMERICA DNA SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 26. NORTH AMERICA DNA SEQUENCING, BY PRODUCT 2018-2026 ($MILLION)
TABLE 27. NORTH AMERICA DNA SEQUENCING, BY APPLICATION 2018-2026 ($MILLION)
TABLE 28. NORTH AMERICA DNA SEQUENCING, BY TECHNOLOGY 2018-2026 ($MILLION)
TABLE 29. NORTH AMERICA DNA SEQUENCING, BY END USER 2018-2026 ($MILLION)
TABLE 30. NORTH AMERICA DNA SEQUENCING, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 31. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 32. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 33. AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
TABLE 34. AGILENT TECHNOLOGIES, INC.: OPERATING SEGMENTS
TABLE 35. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 36. DANAHER CORPORATION: OPERATING SEGMENTS
TABLE 37. ILLUMINA, INC.: COMPANY SNAPSHOT
TABLE 38. ILLUMINA, INC.: OPERATING SEGMENTS
TABLE 39. LI-COR BIOSCIENCES, INC.: COMPANY SNAPSHOT
TABLE 40. LI-COR BIOSCIENCES, INC.: OPERATING SEGMENTS
TABLE 41. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: COMPANY SNAPSHOT
TABLE 42. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: OPERATING SEGMENTS
TABLE 43. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
TABLE 44. THERMO FISHER SCIENTIFIC, INC.: OPERATING SEGMENTS
TABLE 45. ZS GENETICS, INC.: COMPANY SNAPSHOT
TABLE 46. ZS GENETICS, INC.: OPERATING SEGMENTS
TABLE 47. BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 48. BIO-RAD LABORATORIES, INC.: OPERATING SEGMENTS
TABLE 49. MYRIAD GENETICS, INC.: COMPANY SNAPSHOT
TABLE 50. MYRIAD GENETICS, INC.: OPERATING SEGMENTS
LIST OF FIGURES
FIGURE 1. NORTH AMERICA DNA SEQUENCING MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKET
FIGURE 3. TOP WINNING STRATEGIES (%)
FIGURE 4. NORTH AMERICA DNA SEQUENCING MARKET FOR CONSUMABLE, 2018-2026 ($MILLION)
FIGURE 5. NORTH AMERICA DNA SEQUENCING MARKET FOR INSTRUMENT, 2018-2026 ($MILLION)
FIGURE 6. NORTH AMERICA DNA SEQUENCING MARKET FOR SERVICE, 2018-2026 ($MILLION)
FIGURE 7. NORTH AMERICA DNA SEQUENCING MARKET FOR BIOMARKERS AND CANCER, 2018-2026 ($MILLION)
FIGURE 8. NORTH AMERICA DNA SEQUENCING MARKET FOR DIAGNOSTICS, 2018-2026 ($MILLION)
FIGURE 9. NORTH AMERICA DNA SEQUENCING MARKET FOR REPRODUCTIVE HEALTH, 2018-2026 ($MILLION)
FIGURE 10. NORTH AMERICA DNA SEQUENCING MARKET FOR PERSONALIZED MEDICINE, 2018-2026 ($MILLION)
FIGURE 11. NORTH AMERICA DNA SEQUENCING MARKET FOR FORENSICS, 2018-2026 ($MILLION)
FIGURE 12. NORTH AMERICA DNA SEQUENCING MARKET FOR OTHERS, 2018-2026 ($MILLION)
FIGURE 13. NORTH AMERICA DNA SEQUENCING MARKET FOR SYNTHESIS, 2018-2026 ($MILLION)
FIGURE 14. NORTH AMERICA DNA SEQUENCING MARKET FOR ION SEMICONDUCTOR SEQUENCING, 2018-2026 ($MILLION)
FIGURE 15. NORTH AMERICA DNA SEQUENCING MARKET FOR SEQUENCING BY LIGATION, 2018-2026 ($MILLION)
FIGURE 16. NORTH AMERICA DNA SEQUENCING MARKET FOR PYROSEQUENCING, 2018-2026 ($MILLION)
FIGURE 17. NORTH AMERICA DNA SEQUENCING MARKET FOR SINGLE MOLECULE REAL-TIME SEQUENCING, 2018-2026 ($MILLION)
FIGURE 18. NORTH AMERICA DNA SEQUENCING MARKET FOR CHAIN TERMINATION SEQUENCING, 2018-2026 ($MILLION)
FIGURE 19. NORTH AMERICA DNA SEQUENCING MARKET FOR NANOPORE SEQUENCING TECHNOLOGIES, 2018-2026 ($MILLION)
FIGURE 20. NORTH AMERICA DNA SEQUENCING MARKET FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, 2018-2026 ($MILLION)
FIGURE 21. NORTH AMERICA DNA SEQUENCING MARKET FOR PHARMACEUTICAL COMPANIES, 2018-2026 ($MILLION)
FIGURE 22. NORTH AMERICA DNA SEQUENCING MARKET FOR BIOTECHNOLOGY COMPANIES, 2018-2026 ($MILLION)
FIGURE 23. NORTH AMERICA DNA SEQUENCING MARKET FOR PERSONALIZED MEDICINE, 2018-2026 ($MILLION)
FIGURE 24. NORTH AMERICA DNA SEQUENCING MARKET FOR HOSPITALS AND CLINICS, 2018-2026 ($MILLION)
FIGURE 25. NORTH AMERICA DNA SEQUENCING, BY COUNTRY, 2018 (%)
FIGURE 26. U.S. NORTH AMERICA DNA SEQUENCING MARKET, 2018-2026 ($MILLION)
FIGURE 27. CANADA NORTH AMERICA DNA SEQUENCING MARKET, 2018-2026 ($MILLION)
FIGURE 28. MEXICO NORTH AMERICA DNA SEQUENCING MARKET, 2018-2026 ($MILLION)
DNA sequencing is the method of finding out the sequences of four nucleotides that form a DNA strand. The sequence formed with the based-paired structure is used to store a vast amount of genetic information. Scientists can use the sequence information to determine the genes and regulatory instructions contained in the DNA molecule. For many years, DNA sequencing has been used in medicine for the diagnosis and treatment of diseases and epidemiology studies. Furthermore, DNA sequencing can be used for protecting and improving agriculture and the natural environment for humans and wildlife.
Forecast Analysis of the North America DNA Sequencing Market
With the increasing availability, accessibility, and improvement of DNA sequencing in this region, the North America DNA sequencing market is expected to experience prominent growth during the analysis period. Besides, the strong presence of manufacturers of DNA sequencing, equipment, platforms, and technologies in this region is expected to fortify the growth of the market over the analysis period. Moreover, this region is overpowered by local and regional vendors that can gradually make a position in the market which is predicted to bolster the growth of the market in the estimated timeframe.
According to the report published by Research Dive, the North America DNA sequencing market is anticipated to generate a revenue of $9,154 million and grow at a healthy CAGR of 15.9% during the analysis timeframe from 2019 to 2025. The major players of the market include Myriad Genetics, Inc, Abbott Laboratories, Bio-Rad Laboratories, Inc., Agilent Technologies Inc., ZS Genetics, Inc., Danaher Corporation, Thermo Fisher Scientific Inc., Illumina, Inc., Pacific Biosciences of California, Inc., LI-COR Biosciences, Inc., and many more.
Key Developments of the North America DNA Sequencing Market
The key companies operating in the industry are adopting various growth strategies & business tactics such as partnerships, collaborations, mergers & acquisitions, and launches to maintain a robust position in the overall market, which is subsequently helping the North America DNA sequencing market to grow exponentially.
For instance, in February 2022, Element Biosciences Inc., a multi-disciplinary startup focused on innovating genetic analysis tools for research and diagnosis, partnered with Agilent Technologies, a leading American analytical instrumentation development, and manufacturing company. With this partnership, the companies aimed to provide greater access to genomic tools such as SureSelect target enrichment panels for greater accuracy and cost-effectiveness.
In August 2021, Illumina, Inc., a leading American company widely known for applying innovative technologies to the analysis of genetic variation and function, acquired GRAIL, a renowned American biotechnology company focused on early detection tests for multiple cancer. With this acquisition, the companies aimed to make available the test the maximum number of people as quickly as possible, save lives, and transform healthcare.
In August 2020, Ancestry Inc., a well-established American genealogy company, launched its new product named “AncestryHealth”, a new generation DNA sequencing tool, powered by Next Generation Sequencing (NGS) that can help consumers to access important information about their health conditions. This tool can provide comprehensive genetic screening of an expanded set of health conditions such as breast cancer, heart disease, colon cancer, and several blood disorders.
U.S. to Dominate in the Region
The U.S. is expected to hold the maximum share of the market during the forecast period. This is mainly due to the supportive government initiatives and increasing incidences of cancers in the country. Moreover, the growing awareness of DNA sequencing among the population of the U.S. and the rising precautionary measures that are taken by healthcare providers to treat chronic diseases like cancer are predicted to drive the growth of the market during the analysis timeframe.
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
